Two new Israeli studies into the efficacy of the Pfizer coronavirus vaccines suggest that the vaccine greatly reduces virus transmission.
Both studies require further confirmation and …
Two new Israeli studies into the efficacy of the Pfizer coronavirus vaccines suggest that the vaccine greatly reduces virus transmission. Both studies require further confirmation and peer-review, but the results indicate a significant reduction for transmission of both symptomatic and asymptomatic spread. The newest study, published Friday in British medical journal The Lancet, showed an 85 percent reduction in symptomatic COVID-19 within 15 to 28 days, with an overall reduction of infections – including asymptomatic spread – of 75 percent.
